Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J McNatt

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Circulation|January 1, 1989
Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediatorsP Golino, J H Ashton, L M Buja, et al.
Circulation|April 1, 1989
Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosisP Golino, J H Ashton, J McNatt, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1991
Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injuryJ T Willerson, S K Yao, J McNatt, et al.
Circulation|November 7, 2001
Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteriesH V Anderson, J McNatt, F J Clubb, et al.
Circulation|January 1, 1996
Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase geneP Zoldhelyi, J McNatt, X M Xu, et al.
Circulation|December 1, 1994
Abolition of cyclic flow variations in stenosed, endothelium-injured coronary arteries in nonhuman primates with a peptide fragment (VCL) derived from human plasma von Willebrand factor-glycoprotein Ib binding domainA I McGhie, J McNatt, N Ezov, et al.
The American Journal of Physiology|February 1, 1992
Thrombin inhibition enhances tissue-type plasminogen activator-induced thrombolysis and delays reocclusionS K Yao, J McNatt, H V Anderson, et al.
Circulation Research|January 1, 1992
ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteriesS K Yao, J C Ober, J McNatt, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Circulation|January 1, 1989
Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediatorsP Golino, J H Ashton, L M Buja, et al.
Circulation|April 1, 1989
Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosisP Golino, J H Ashton, J McNatt, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1991
Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injuryJ T Willerson, S K Yao, J McNatt, et al.
Circulation|November 7, 2001
Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteriesH V Anderson, J McNatt, F J Clubb, et al.
Circulation|January 1, 1996
Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase geneP Zoldhelyi, J McNatt, X M Xu, et al.
Circulation|December 1, 1994
Abolition of cyclic flow variations in stenosed, endothelium-injured coronary arteries in nonhuman primates with a peptide fragment (VCL) derived from human plasma von Willebrand factor-glycoprotein Ib binding domainA I McGhie, J McNatt, N Ezov, et al.
The American Journal of Physiology|February 1, 1992
Thrombin inhibition enhances tissue-type plasminogen activator-induced thrombolysis and delays reocclusionS K Yao, J McNatt, H V Anderson, et al.
Circulation Research|January 1, 1992
ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteriesS K Yao, J C Ober, J McNatt, et al.
Pageof 3